The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to participate in the 2023 NIIMBL eXperience Program, the largest cohort to date since the program launched in 2019. Students were selected from 34 educational institutions across the United States to...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) launches NIIMBL bioLOGIC, a pilot program designed to bring awareness to and foster interest in careers in the biopharmaceutical manufacturing industry. NIIMBL has partnered with the North Carolina Biotechnology Center and has selected Southern High School of Energy...

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.

There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...

Sporting white hard hats, bright safety vests and protective goggles, Delaware Gov. John Carney and a small group of officials visited the construction site of the University of Delaware’s Ammon Pinizzotto Biopharmaceutical Innovation Center on Tuesday, Feb. 5. The tour offered a glimpse into the future of growth and innovation at the University.

“...

The University of Delaware plans a six-story, 200,000-square-foot research facility at the University of Delaware’s STAR Campus to house the national headquarters for the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), slated to open in early 2020.

The groundbreaking ceremony will be on Monday, October 23rd. The...